Baird Medical Investment Holdings Ltd .

Research Baird Medical Investment Holdings Ltd . (BDMD) on Bullrun: market cap USD 36.90M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 36.90M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 22.54M-USD 27.28M-USD 1.39M83.8%-0.98USD 178.32KUSD 8.72MUSD 31.37M
FY2024USD 37.04MUSD 12.45M-USD 9.17M88.2%0.57USD 2.97MUSD 4.31MUSD 39.66M
FY2023USD 31.46MUSD 10.55M-USD 3.66M86.6%0.51USD 1.51MUSD 2.43MUSD 35.75M
FY2022USD 35.09MUSD 12.77M-USD 5.42M79.9%0.49USD 1.71Mn/aUSD 25.78M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-25USD 36.90Mn/an/an/a
20252025-12-31USD 41.82Mn/an/an/a
20242024-12-31USD 194.22Mn/an/an/a

About Baird Medical Investment Holdings Ltd .

Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. The company offers microwave ablation apparatus and needles; and long and fine microwave ablation needles for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps, and uterine fibroids, as well as soft tissue ablation.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Baird Medical Investment Holdings Ltd .'s market cap?

Baird Medical Investment Holdings Ltd .'s market capitalization is USD 36.90M.

What does Baird Medical Investment Holdings Ltd . do?

Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. The company offers microwave ablation apparatus and needles; and long and fine microwave ablation needles for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps, and uterine fibroids, as well as soft tissue ablation. It sells its products through third-party distributors.